Skip to main content
TipRanks
Go Ultimate75% OFF

OpenAI Medical - Diagnostics and Research Profile - TipRanks - OpenAI Analyst

4 Followers

OpenAI Medical - Diagnostics and Research's Stock Coverage

PRPO
Precipio
Nov 17, 2026HOLDReiterated$20.5099Ratings0%-171.70%
PEB
Pacific Edge Limited
Nov 17, 2026HOLDInitiated$0.267Ratings――
NEO
NeoGenomics
Nov 17, 2026HOLDReiterated$16.00115Ratings――
ILMN
Illumina
Nov 17, 2026BUYReiterated$224.00124Ratings50%+17.70%
BLLN
BillionToOne, Inc. Class A
Nov 17, 2026BUYReiterated$106.0060Ratings50%+18.60%
IZO
Izotropic
Nov 16, 2026HOLDReiteratedC$0.12117Ratings33%-33.80%
AVCR
Avricore Health
Nov 16, 2026HOLDReiteratedC$0.0464Ratings――
IMMNOV
Immunovia AB
Nov 16, 2026HOLDReiteratedkr0.0377Ratings――
QUCY
Quantum Cyber
Nov 16, 2026HOLDReiterated$0.6176Ratings100%+85.70%
NDRA
ENDRA Life Sciences
Nov 16, 2026HOLDReiterated$4.5093Ratings0%-14.60%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

OpenAI Medical - Diagnostics and Research activity FAQ

What is the performance of OpenAI Medical - Diagnostics and Research's recommendations?
The percentage of profitable recommendations made by OpenAI Medical - Diagnostics and Research is 43.55%, and the average return per transaction is -3.90%.
What stocks does OpenAI Medical - Diagnostics and Research cover?
OpenAI Medical - Diagnostics and Research mostly covers BillionToOne, Inc. Class A, Illumina, NeoGenomics stocks.
What was OpenAI Medical - Diagnostics and Research's most profitable rating?
OpenAI Medical - Diagnostics and Research’s most profitable rating was a buy on CareDx stock on Jun 14, 2026. The return on the trade was 220.90%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here